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ulse  pressure ampliﬁcation
oronary  artery disease
adial  applanation tonometry
a  b  s  t  r  a  c  t
Background:  Augmentation  index  (AIx)  and  pulse  pressure  ampliﬁcation  (PPA,  here  the  aortic/brachial
pulse  pressure  ratio)  are  an  age-related  emerging  risk  factor  for cardiovascular  disease.  However,  it  has
not  been  clearly  shown  that  AIx and  PPA  predict  a high  risk  of  coronary  artery  disease  (CAD).
Objectives: The  aim  of  the study  was  to  investigate  the  association  between  non-invasively  measured
aortic  wave  reﬂection  (AWR)  and  PPA  and CAD.
Methods: The  study  group  consisted  of 80 patients  who  were  admitted  to  our  institute  for  elective  coro-
nary  angiography.  We non-invasively  measured  augmentation  pressure  (AP),  AIx, and  PPA  using  radial
applanation  tonometry.
Results: When  the  extent  of  CAD  was  divided  by  no or  minimal  CAD,  1- or  2- and  3-vessel  disease  (VD),
there  was  a signiﬁcant  association  between  the  extent  of  CAD  and  AIx and  PPA  in  patients  aged  <65  years,
but  not  in  patients  aged  ≥65  years.  In  multivariate  regression  analysis  after  controlling  the  traditional  risk
factors,  the odds  ratio  of  having  3VD  was  signiﬁcant  in patients  aged  <65  years:  2.15 (1.04–4.44;  p =  0.039)
per  5%  increase  of  AIx and  2.02  (1.15–3.55;  p =  0.015)  per  0.05  increase  of  PPA, but not  in patients  aged
≥65  years.  The  severity  of  CAD  expressed  as a  Gensini  score  showed  a signiﬁcant  correlation  with  AP,
AIx,  and PPA  in patients  aged  <65 years,  but not  in patients  aged ≥65  years.
Conclusion: Increasing  of non-invasively  measured  AWR  and  PPA  is  related  to  the severity  of CAD,  par-
ticularly  in  younger  patients  up to 65 years  of  age.
©  2ntroduction
Central pulse pressure (PP) and arterial stiffness of the large,
lastic conduit arteries are considered a risk marker of vascular
ging, as well as a new biomarker of cardiovascular (CV) disease
1–7]. Recently, the most commonly used non-invasive markers to
valuate the arterial stiffness are aortic pulse wave velocity (PWV)
nd wave reﬂection using radial applanation tonometry. The aortic
ressure wave is composed of a forward traveling wave gener-
ted by left ventricular ejection and a later arriving reﬂected wave
rom the periphery [8–11]. As aortic and arterial stiffness increase,
ransmission of both forward and reﬂected PWV  increase, which
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causes the reﬂected wave to arrive earlier in the aorta and to aug-
ment pressure in late systole. Therefore, augmentation of the aortic
pressure wave is a manifestation of wave reﬂection. This can be
expressed in absolute terms as the augmentation pressure (AP), or
as a percentage of PP as the augmentation index (AIx).
Aortic PP physiologically is lower than brachial PP. The disparity
between aortic and brachial PP, called PP ampliﬁcation (PPA), is
expressed as either the difference or the ratio of these 2 pressures.
In this study, we  deﬁned the aortic/brachial PP ratio as PPA. PPA
might be closely correlated to AP and AIx, because PPA is driven
mainly by differences in vessel stiffness and wave reﬂection.
So  far, there have been some studies that reported that non-
invasively measured (NIM) aortic AIx was  related to coronary artery
disease (CAD), CV risk factors and major adverse CV events (MACEs)
[12–18]. Also, there were some reports that increased NIM PPA was
related to CV risk factors [19] and predicts CV mortality [20]. In con-
trast, there were some studies that reported that aortic AIx and PPA
were not related to CAD [8,21]. Importantly, AIx and PPA increase
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ears of age [19,22,23]. Therefore, applying NIM aortic wave reﬂec-
ion (AWR) and PPA to the general age group with a high risk of CAD
emains controversial.
We  NIM the indices of AWR  and PPA and investigated their
elationship with CAD in this study. Then, we evaluated whether
IM AWR  and PPA could be applied to the general age group with
uspected or conﬁrmed CAD.
ethods
tudy population
We  included 80 consecutive patients from March 2010 to June
010 who underwent elective coronary angiography (CAG) for the
valuation of CAD and follow-up of prior coronary intervention.
atients who either had acute myocardial infarction (MI) within
 month before angiography, impaired left ventricular function
deﬁned as ejection fraction below 50%), hemodynamically sig-
iﬁcant valvular heart disease, renal insufﬁciency, or cancer were
xcluded from the analysis.
Fasting blood samples were taken before CAG for the analysis
f high-density lipoprotein (HDL) cholesterol, triglycerides, low-
ensity lipoprotein (LDL) cholesterol, high sensitivity C-reactive
rotein (Hs CRP), and creatinine. The height and weight for each
atient were recorded. Body mass index (BMI) was  calculated
s weight divided by height squared (kg/m2). Hypertension was
resent with repeated measurements ≥140 mmHg  systolic blood
ressure (SBP) and/or ≥90 mmHg  diastolic BP (DBP) or permanent
ntihypertensive drug treatment. Diabetes mellitus was deﬁned as
 fasting blood glucose concentration ≥126 mg/dL or antihyper-
lycemic drug treatment. Current smoking was deﬁned as having
moked the last cigarette less than 1 week before CAG.
We  received approval from the institutional review board of Inje
niversity Sanggye Paik Hospital to conduct all these analyses. All
ubjects included gave their informed consent at the time of the
xamination.
P measurement and pulse wave analysis
Prior to the study, all antihypertensive medicines were
ithdrawn, and the patients had fasted for at least 12 h. BP mea-
urement and pulse wave analysis were performed in supine
osition after 10 min  rest. Measurements were made under stan-
ardized conditions between 8 AM and 10 AM,  and were done
rior to the CAG. The peripheral BP was recorded non-invasively
sing an oscillometric method (Microlife BP 3BM1-3®, Widnau,
witzerland) at the brachial artery. Pulse wave analysis (PWA)
as performed non-invasively with the commercially available
phygmoCor® system (AtCor Medical, Sydney, Australia). In brief,
eripheral pressure waveforms were recorded from the radial
rtery at the wrist using applanation tonometry with a high
delity micromanometer. After 20 sequential waveforms had been
cquired, a validated [24], generalized transfer function was  used
o generate the corresponding central aortic pressure waveform.
P, AP, and AIx were derived from the measurement of PWA  [25].
n this study, we deﬁned the NIM aortic/brachial PP ratio as PPA.
nly high-quality recordings, deﬁned as an in-device quality index
0% and acceptable curves on visual inspection by the investigator,
ere included in the analysis.
easurement  of angiographic variablesCAG was performed mainly through the percutaneous radial
pproach using the standard technique. CAG was performed
fter intra-arterial infusion of nitroglycerin for preventing radial
rtery spasm. The three major coronary vessels (the left anteriorology 62 (2013) 131–137
descending  artery, the circumﬂex artery, and the right coronary
artery) were considered for evaluation of the extent of coronary
atherosclerosis. Optimal views of the arteries from all technically
suitable angiograms were analyzed. The guiding catheter was  used
as the reference dimension. A signiﬁcantly diseased artery was
deﬁned as having ≥50% stenosis in at least one of its segments
or having prior coronary intervention. Signiﬁcant left main artery
stenosis was  coded as two-vessel disease. The severity of CAD was
assessed by Gensini scoring system. This scoring system assigns
a different severity score depending on geometrically increasing
severity of the lesion, the cumulative effects of multiple obstruc-
tions, and the signiﬁcance of their locations [26]. The Gensini
score was  used widely in previous years to assess the severity and
extent of coronary atherosclerosis. Assessment of extent of CAD
and Gensini score in patients undergoing follow-up angiography
was carried out using the angiographic ﬁndings of prior coronary
intervention.
Statistical analysis
All  data were analyzed using the SPSS 15.0 software (SPSS, Cary,
NC, USA). Categorical variables were reported as percentages and
continuous variables as means ± standard deviation (SD). Normally
distributed continuous variables were compared using analysis of
variance (ANOVA). A stepwise logistic regression analysis was per-
formed to evaluate the independent effects of AIx and PPA on the
risk of having 3 vessel disease (VD), starting with a model including
a number of potential confounders (age, gender, smoking, hyper-
tension, diabetes, LDL, and HDL levels). Correlations between the
indices of AWR  and PPA and Gensini score were calculated using
univariate linear regression analysis. A general linear model using
the same confounders as used in the logistic regression analysis was
employed in the multivariate linear regression analysis in evalua-
tion of the independent effects of the indices of AWR  and PPA on
the Gensini score. A p-value of <0.05 was considered statistically
signiﬁcant.
Results
Baseline clinical characteristics and hemodynamic indices
The  study group consisted of 80 patients. The mean age of partic-
ipants was 62.7 ± 10.1 years, 66.3% were men, 20.0% were current
smokers, 77.5% were hypertensive, 26.3% had diabetes, 10% had
acute MI,  and 31.3% had undergone prior coronary intervention.
Baseline clinical characteristics of total, younger (up to 65 years of
age, 40 patients) and older groups (older than 65 years of age, 40
patients) are summarized in Table 1. The distributions of hyper-
tension, diabetes, or current smoking status were not signiﬁcantly
different between both groups. Also, the laboratory ﬁndings asso-
ciated with coronary atherosclerosis and medications were not
signiﬁcantly different between the two groups. Mean values of
hemodynamic indices of total, younger, and older groups are sum-
marized in Table 2. Among the hemodynamic indices, brachial and
aortic PP, AP, AIx, and PPA were signiﬁcantly higher in older groups.
Interestingly, AIx and PPA increased with aging in a non-linear
manner, and tended to plateau after 65 years of age (Fig. 1).
Aortic  wave reﬂection and pulse pressure ampliﬁcation and the
extent  of CAD
CAG  revealed that 77.5% of the patients had CAD. When the
extent of CAD was expressed as no or minimal CAD, 1- or 2- and
3-VD, PPA was only signiﬁcantly associated with the extent of CAD
(p = 0.047) among the markers of arterial stiffness in total patients.
In addition, there was  more signiﬁcant association between the
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Table  1
Baseline clinical characteristics of the study population.
Variable Total (n = 80) Age < 65 (n = 40) Age ≥ 65 (n = 40) p-Value*
Age (years) 62.7 ± 10.1 54.3 ± 5.8 71.2 ± 5.3 <0.001
Gender  (male), n (%) 53 (66.3%) 29 (72.5%) 24 (60%) 0.34
Hypertension, n (%) 16 (20.0%) 28 (70%) 34 (85%) 0.18
Diabetes,  n (%) 62 (77.5%) 10 (25%) 11 (27.5%) 1.00
Previous  MI,  n (%) 21 (26.3%) 3 (7.5%) 5 (12.5%) 0.71
Previous  CAD, n (%) 8 (10.0%) 10 (25%) 15 (37.5%) 0.34
Current  smokers, n (%) 25 (31.3%) 10 (25.0%) 6 (15%) 0.40
Body  mass index (kg/m2) 24.5 ± 2.9 24.8 ± 3.0 24.1 ± 2.8 0.27
LDL  cholesterol (mg/dL) 105.5 ± 32.6 108.0 ± 36.3 102.8 ± 28.5 0.49
HDL  cholesterol (mg/dL) 49.0 ± 11.4 49.8 ± 12.1 48.3 ± 10.8 0.57
Triglyceride  (mg/dL) 147.2 ± 88.4 164.2 ± 103.0 129.8 ± 67.3 0.08
Hs  CRP (mg/dL) 0.17 ± 0.22 0.14 ± 0.17 0.20 ± 0.26 0.86
Creatinine  (mg/dL) 1.03 ± 0.19 1.03 ± 0.2 1.04 ± 0.2 0.88
Medications  (%)
Aspirin  72 (90.0%) 37 (92.5%) 35 (87.5%) 0.71
Clopidogrel  71 (88.8%) 38 (95%) 33 (82.5%) 0.15
ACE  inhibitors 26 (32.5%) 11 (27.5%) 15 (37.5%) 0.47
Angiotensin  receptor blockers 24 (30%) 10 (25.0%) 14 (35.0%) 0.47
-Blockers  34 (42.5%) 14 (35.0%) 20 (50.0%) 0.26
Calcium  channel blockers 25 (31.3%) 10 (25.0%) 15 (37.5%) 0.34
Diuretics  8 (10.0%) 3 (7.5%) 5 (12.5%) 0.71
Statins  55 (68.7%) 26 (65.0%) 29 (72.5%) 0.63
Nitrates  77 (96.3%) 39 (97.5%) 38 (95.0%) 1.00
-Adrenergic  blockers 1 (1.3%) 0 (0.0%) 1 (2.5%) 1.00
MI,  myocardial infarction; CAD, coronary artery disease; LDL, low-density lipoprotein; HDL, high-density lipoprotein; Hs CRP, high sensitivity C-reactive protein; ACE,
angiotensin-converting enzyme.
* p-Value is comparison between younger (<65 years of age) and older (≥65 years of age) patient group.
Table 2
Mean  values of hemodynamic indices of the study population.
Variable Total (n = 80) Age < 65 (n = 40) Age ≥ 65 (n = 40) p-Value*
Brachial SBP (mmHg) 135.5 ± 17.8 132.6 ± 16.8 138.4 ± 18.6 0.15
Brachial  DBP (mmHg) 76.0 ± 11.3 78.2 ± 12.3 73.8 ± 9.8 0.08
Brachial  MBP  (mmHg) 97.2 ± 13.1 97.8 ± 13.7 96.7 ± 12.6 0.71
Brachial  PP (mmHg) 59.5 ± 14.6 54.4 ± 12.8 64.6 ± 14.7 0.001
Aortic  SBP (mmHg) 126.2 ± 17.6 122.7 ± 16.5 129.6 ± 18.2 0.08
Aortic  DBP (mmHg) 77.0 ± 11.5 79.2 ± 12.6 74.8 ± 10.0 0.09
Aortic  MBP  (mmHg) 93.4 ± 12.2 93.7 ± 13.0 93.0 ± 11.5 0.82
Aortic  PP (mmHg) 49.0 ± 13.9 43.3 ± 11.3 54.8 ± 14.1 < 0.001
AP  (mmHg) 15.8 ± 8.4 12.5 ± 6.7 19.2 ± 8.6 <0.001
AIx  (%) 30.8 ± 11.0 27.8 ± 10.8 33.9 ± 10.4 0.01
PPA  0.82 ± 0.09 0.80 ± 0.09 0.85 ± 0.07 0.01
SBP, systolic blood pressure; DBP, diastolic blood pressure; MBP, mean blood pressure; PP, pulse pressure; AP, augmentation pressure; AIx, augmentation index; PPA, pulse
pressure  ampliﬁcation.
* p-Value is comparison between younger (<65 years of age) and older (≥65 years of age) patient group.
Fig. 1. The relationship of non-invasively measured (A) augmentation index and (B) pulse pressure ampliﬁcation and age. Augmentation index and pulse pressure ampliﬁ-
cation increased with aging in a non-linear manner, and tended to plateau after 65 years of age (dotted line).
AIx,  augmentation index; PPA, pulse pressure ampliﬁcation.
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Table  3
Mean  values of aortic wave reﬂection and pulse pressure ampliﬁcation according to
the number of diseased coronary vessels.
Variable No or minimal CAD 1- or 2-VD 3VD p-Value
All patients, n = 80 17 49 14
AP (mmHg) 16.8 ± 8.4 14.6 ± 8.0 18.7 ± 9.1 0.24
AIx (%) 31.8 ± 11.1 29.4 ± 10.9 34.6 ± 10.7 0.27
PPA 0.81 ± 0.09 0.81 ± 0.08 0.87 ± 0.10 0.047
Age < 65, n = 40 9 25 6
AP (mmHg) 10.9 ± 5.6 11.7 ± 6.4 17.8 ± 7.6 0.092
AIx (%) 25.4 ± 10.1 26.1 ± 10.3 38.0 ± 9.0 0.036
PPA 0.76 ± 0.08 0.78 ± 0.08 0.91  ± 0.07 0.002
Age  ≥ 65, n = 40 8 24 8
AP (mmHg) 23.4 ± 5.4 17.7 ± 8.6 19.4 ± 10.6 0.27
AIx (%) 38.9 ± 7.3 32.8 ± 10.7 32.1 ± 11.7 0.32































AAD, coronary artery disease; VD, vessel disease; AP, augmentation pressure; AIx,
ugmentation index; PPA, pulse pressure ampliﬁcation.
xtent of CAD and AIx (p = 0.036) and PPA (p = 0.002) in the younger
roup. As the extent of CAD was more severe, AP, AIx, and PPA were
ore increased in the younger group. However, there was  no asso-
iation between the extent of CAD and AP, AIx, and PPA in the older
roup (Table 3).
ugmentation index and pulse pressure ampliﬁcation and risk of
VD
In the total patient group, the risk of having 3VD per 0.05
ncrease of PPA was signiﬁcant in univariate (OR 1.25; 95% CI
.04–1.50; p = 0.019) and multivariate (OR 1.31; 95% CI 1.05–1.63;
 = 0.018) logistic regression analysis. In the younger group, the risk
f having 3VD per 5% increase of AIx was signiﬁcant in univariate
OR 1.80; 95% CI 1.09–2.98; p = 0.022) and multivariate (OR 2.15;
5% CI 1.04–4.44; p = 0.039) logistic regression analysis. Also, the
isk of having 3VD per 0.05 increase of PPA was signiﬁcant in uni-
ariate (OR 1.64; 95% CI 1.13–2.37; p = 0.009) and multivariate (OR
.02; 95% CI 1.15–3.55; p = 0.015) logistic regression analysis. How-
ver, the risk of having 3VD per 5% increase of AIx and 0.05 increase
f PPA was not signiﬁcant in the older group (Table 4).
ortic  wave reﬂection and pulse pressure ampliﬁcation and the
everity  of CAD
In  the total patient group, the severity of CAD expressed as a
ensini score showed a signiﬁcant correlation with AIx and PPA in
nivariate and multivariate linear regression analysis. This correla-
ion was shown to be age-dependent: univariate linear regression
nalysis showed that higher AP (r = 0.496, p = 0.001), AIx (r = 0.510,
 = 0.001), and PPA (r = 0.507, p = 0.001) were signiﬁcantly corre-
ated with Gensini score in the younger group, but not correlated
able 4
dds  ratios for the association between the augmentation index per 5% and pulse pressu
Variable N 3VD (%) Univariate an
Odds ratio (9
All patients 80 14(17.5%)
AIx  per 5% 1.53 (0.93–1.
PPA  per 0.05 1.25 (1.04–1.
<65  years of age 40 6 (15%)
AIx  per 5% 1.80 (1.09–2.
PPA  per 0.05 1.64 (1.13–2.
≥65  years of age 40 8 (20%)
AIx  per 5% 0.91 (0.63–1.
PPA  per 0.05 1.01 (0.81–1.
Ix, augmentation index; PPA, pulse pressure ampliﬁcation; VD, vessel disease; CI, conﬁd
* Age, gender, smoking, hypertension, diabetes, low-density lipoprotein cholesterol, anology 62 (2013) 131–137
in  the older group (Fig. 2). Similarly, multivariate linear regres-
sion analysis showed that higher AP (r2 = 0.456, p < 0.001), AIx
(r2 = 0.426, p < 0.001), and PPA (r2 = 0.418, p = 0.001) were signiﬁ-
cantly correlated with Gensini score in the younger group, but not
correlated in the older group (Table 5).
Discussion
To the best of our knowledge, this is the second study inves-
tigating the relation of NIM AWR  to the CAD and the ﬁrst study
investigating the relation of NIM PPA to CAD in different age
groups. Weber et al. showed that NIM AWR  was  associated with
an increased risk of CAD in a younger group, but not in an older
group [13]. Our study also showed that NIM AIx and PPA were asso-
ciated with an increased risk of 3VD only in the younger group. In
addition, increased NIM AWR  and PPA were correlated with the
severity of CAD using Gensini score exclusively in the younger
group as well. However, Weber et al. did not propose a mech-
anism that NIM AWR  was  not associated with CAD in the older
group.
We postulated some possible reasons for the variance of NIM
AWR and PPA between different age groups. First, AWR  and PPA are
inﬂuenced by several factors: age, gender, height, and underlying
disease. Particularly, the Anglo-Cardiff Collaborative Trial (ACCT)
showed that NIM AIx and PPA increases with aging in a non-linear
manner, and tends to plateau after 50–60 years of age [19,22]. Our
data also showed that NIM AIx and PPA increases with aging in a
non-linear manner, and tends to plateau. Therefore, NIM AWR  and
PPA are more sensitive markers of arterial stiffness and CV risk in
younger groups. Second, NIM AWR  and PPA are dependent on wave
velocity and the magnitude of wave reﬂection. The ACCT showed
that in contrast to younger groups, older groups manifest more
marked change of NIM aortic PWV  [22]. Accordingly, NIM aortic
PWV is a more sensitive marker of arterial stiffness, and it may
affect wave reﬂection more severely in older groups. Both our and
Weber et al.’s [13] studies showed that NIM AWR  was not correlated
with CAD in older groups. Also, Janner et al. showed the association
between NIM AIx and traditional CV risk factors was attenuated in
subjects >60 years [17]. These ﬁndings may  be due to the effect of
aortic PWV  on wave reﬂection and pressure ampliﬁcation. In the
older group, AIx and PPA change little while aortic PWV  increases
markedly, suggesting that the rise in AP is driven by an earlier return
of the reﬂected wave and a less compliant aorta rather than by pre-
dominant changes in the magnitude of wave reﬂection [22]. Finally,
the controversy of generalized transfer function in radial applana-
tion tonometry is that non-invasive BP recordings in the brachial
artery are used to calibrate the radial pulse wave [27–30]. The out-
put error at the aorta is associated with the input errors at the radial
artery, which is attributable to the under- or over-estimation of NIM
aortic SBP and DBP compared to invasively measured, depending
re ampliﬁcation per 0.05 and the risk of 3-vessel disease according to the age.
alysis Multivariate analysis*
5% CI) p Odds ratio (95% CI) p
63) 0.15 1.24 (0.91–1.70) 0.17
50) 0.019 1.31 (1.05–1.63) 0.018
98) 0.022 2.15 (1.04–4.44) 0.039
37) 0.009 2.02 (1.15–3.55) 0.015
31) 0.60 0.90 (0.60–1.37) 0.91
24) 0.97 1.06 (0.84–1.33) 0.63
ence interval.
d high-density lipoprotein cholesterol were included in the initial model.
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iig. 2. The correlation of non-invasively measured (A) augmentation index and (B)
sing  Gensini score in univariate linear regression analysis. Left, younger (<65 year
Ix,  augmentation index; PPA, pulse pressure ampliﬁcation.
n which non-invasive technique is applied [31], and the presence
f brachial-to-radial pressure ampliﬁcation [32]. Consequently, the
IM aortic PP is usually underestimated [28–30] compared to inva-
ively measured aortic PP. Particularly, brachial-to-radial pressure
mpliﬁcation is lower and underestimation of aortic PP is more
rofound in older groups than in younger groups. Therefore, NIM
WR and PPA in older groups are different from those measured
n younger groups when the calibration using brachial BP in radial
pplanation tonometry is applied. And NIM AWR  and PPA in older
roups might not make signiﬁcant differences according to the
xtent and severity of CAD in our study.
NIM AWR  and PPA showed similar relation with aging and the
xtent and severity of CAD in our study. These similar relations
howed that PPA also could be a marker of arterial stiffness, because
tiffened artery increased wave reﬂection and PWV, and ﬁnally
ncreased aortic PP and PPA.pressure ampliﬁcation and the severity of coronary artery disease according to age
e); right, older (≥65 years of age) patient group.
The  mechanism by which severity of atherosclerosis in CAD
relates to parameters of arterial stiffness is not clear. A possible
explanation for the relationship between parameters of arte-
rial stiffness and atherosclerosis is provided by the concept of
bidirectionality—that is, elevated parameters of arterial stiffness
are both a cause and a consequence of atherosclerosis. Elevated
aortic PP promotes vascular endothelial damage, an antecedent
to atherosclerosis, which results in large-vessel stiffening and
increased wave reﬂection and PWV, thus, further amplifying aortic
PP [33]. In addition, increased aortic PP may  exacerbate myocardial
ischemia as a result of increased afterload and reduced coronary
perfusion [33].We  grouped the patients according to their age below and above
65 years. As a result, the mean age of the younger group in our
study was  54.3 ± 5.8 years, which was older than Weber et al.’s
study (52.4 ± 5.5 years) [13] and younger than Covic et al.’s study
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Table  5
The  linear regression analysis of indices of aortic pulse wave reﬂection and pulse
pressure ampliﬁcation and the severity of coronary artery disease using Gensini
score  according to the age.
Variable Univariate analysis Multivariate analysis*
r2 p r2 p
All patients, n = 80
AP (mmHg) 0.040 0.08 0.107 0.04
AIx (%) 0.078 0.014 0.146 0.007
PPA 0.081 0.012 0.133 0.013
Age < 65, n = 40
AP (mmHg) 0.246 0.001 0.456 <0.001
AIx (%) 0.260 0.001 0.426  <0.001
PPA 0.257 0.001 0.418 0.001
Age ≥ 65, n = 40
AP (mmHg) 0.004 0.70 0.197 0.89
AIx (%) <0.001 1.00 0.198 0.81
PPA 0.002 0.81 0.197 0.87
AP, augmentation pressure; AIx, augmentation index; PPA, pulse pressure ampliﬁ-
cation.
* Age, gender, smoking, hypertension, diabetes, low-density lipoprotein choles-











































Mean  values of augmentation index and pulse pressure ampliﬁcation according to
the medication.
Variable No medication Medication p-Value
ACE inhibitors, n (%) 54  (67.5%) 26 (32.5%)
AIx (%) 31.2 ± 11.3 30.1 ± 10.4 0.68
PPA 0.82 ± 0.92 0.82 ± 0.74 0.80
Angiotensin receptor blockers, n (%) 56 (70%) 24 (30%)
AIx (%) 29.5 ± 11.4 33.9 ± 9.5 0.08
PPA 0.81 ± 0.09 0.84 ± 0.07 0.15
-Blockers, n (%) 46 (57.5%) 34 (42.5%)
AIx (%) 29.5 ± 12.6 32.5 ± 8.2 0.21
PPA  0.81 ± 0.09 0.84 ± 0.08 0.19
Calcium channel blockers, n (%) 55 (68.7%) 25 (31.3%)
AIx (%) 31.4 ± 11.6 29.6 ± 9.6 0.47
PPA 0.82 ± 0.09 0.82 ± 0.08 0.69
Statins, n (%) 25 (31.3%) 55 (68.7%)
AIx (%) 29.4 ± 12.9 31.5 ± 10.1 0.48
PPA 0.80 ± 0.09 0.83 ± 0.08 0.18
preclinical patients with cardiovascular risk factors: assessment by the new
technique of 2D strain echocardiography. J Cardiol 2011;57:354–9.
[7] Park HE, Choi SY, Kim MK,  Oh BH. Cardio-ankle vascular index reﬂects coronaryodel.
55.7 ± 13.2 years) [18]; however, the mean age of the younger
roup in our and Weber et al.’s studies and the mean age of Covic
t al.’s study was younger than Wykretowicz et al.’s study (58 ± 1
ears) [8] which reported negative correlation of NIM AIx and PPA
nd CAD. Also, some studies showed that the NIM aortic PWV  was
elated to CAD [18,21,34–36]; the mean age of the subjects in those
tudies was mostly older than the mean age of the younger group
n our and Weber et al.’s studies (Covic et al. [18]: 55.7 ± 13.2 years;
cLeod et al. [34]: 60 ± 1.5 years; Lee et al. [35]: 57.0 ± 10.5 years).
herefore, these ﬁndings of previous and our studies support that
IM AWR  and PPA are more sensitive markers of arterial stiffness
n younger groups and NIM aortic PWV  is a more sensitive marker
n older groups. It is difﬁcult to deﬁne the cut-off value of age of
V patients for application of the AWR, PPA, and PWV. Generally,
0 years of age proposed by the ACCT is now a widely accepted
alue; nevertheless, it must be taken into consideration that the
CCT was investigated on healthy populations [19,22]. Therefore, a
arge clinical trial of NIM arterial stiffness including AWR, PPA, and
WV  from high-risk CV patients is necessary.
Previous studies reported that medication can have substan-
ially different effects on NIM aortic pressures and hemodynamics
espite a similar impact on brachial BP [37–39]. However, we could
ot ﬁnd a relationship between medication and NIM AWR  and
PA, because this study is cross-sectional and we could not con-
rol patients’ medication history including dose and duration. Mean
alues of AIx and PPA according to the medication are summarized
n Table 6.
Our  study is limited in that the study population was  small in
umber, with a single center and uneven distribution. The portion
aving signiﬁcant CAD was higher in the male group in our study.
lthough gender is known to affect AWR  and gender distribution,
he ﬁndings of our study are in agreement with previous studies
13,18]. In addition, a recent study showed that high aortic AIx pre-
icts mortality and CV events in men  from a general population, but
ot in women [40]. Further studies of NIM AWR  and PPA in high-
isk CV patients are needed before considering in clinical practice
egardless of gender. Also, some patients for follow-up angiogra-
hy after prior coronary intervention were included in the CAD
roup. Although the time point of AWR  and PPA measurement was
ifferent in our CAD group, previous studies [41,42] also showed
hat parameters of NIM aortic stiffness increased signiﬁcantly in
atients with veriﬁed CAD. Finally, simultaneous measurement ofACE, angiotensin-converting enzyme; AIx, augmentation index; PPA, pulse pressure
ampliﬁcation.
the PWV, which would be necessary to clarify the relation of aortic
PWV and CAD in older groups, was  not conducted in our study.
Conclusion
Increased  NIM AWR  and PPA was  correlated with the severity
of CAD in younger patients up to 65 years of age. Therefore, NIM
large artery stiffness including AWR  and PPA can be considered as
a useful independent risk marker of CAD in younger patients.
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